CTCA Administrative & Hospitality Services Positions Are Available For Qualified Applicants

Most people wrongly assume that the fight against cancer is all about the treatment process. This is not true. Cancer patients must have funding to carry on this fight. They also need administrative  insurance support. These are just some of the different factors that influence how a person receives cancer treatment and how their recovery process will ultimately play out.

Administrative and Hospitality Service Positions are being offered at the Cancer Treatment Centers of America or CTCA. This is a cancer fighting hospital network that provides it services for a profit. When it comes to fighting cancer, the CTCA is one of the premiere cancer treatment organizations in the United States. The facilities use updated cancer treatment options to maximize patient life expectancy. Medical staff at the CTCA has also been able to eliminate cancerous cells in some patients.

You might not think that a cancer treatment center would need a warehouse worker but think again. The equipment, medical supplies and even specific cancer fighting medications are often shipped to one of the five different Cancer Treatment Centers of America hospitals. Once these shipments arrive, a person will have to process them in before they can be delivered to the medical professionals for patient care. Warehouse Associate Reps are needed for this position.

Cancer is a disease that takes away life if treatment is not successful. People with cancer are trying to stay positive and keep their spirits up and a chaplain is the type of person they need to help with this task. Chaplain positions are also available at the CTCA. These individuals can provide spiritual guidance to patients who are struggling with the concept of death while they receive treatment for cancer. Various CTCA locations will post these positions according to their needs.

A Patient Access Advocate is needed to verify insurance for treatment and to figure out if a patient will need more coverage for treatment options. They can also help patients to find more insurance that will help to provide longer care. Again, people might think that the fight against cancer is just about the disease. While that is true; this fight is also about having enough funding to ensure that a victory can be achieved. Many patients are defeated in the fight against cancer because they simply do not have enough financial support to continue the struggle. These positions are available at the CTCA headquarters.

Driver are needed to transport patients to off-site locations when needed. Cooks and nutritionist positions are available for fixing meals for patients. These meals can be regular entrees or specialized foods that can be used in the fight against cancer. There are many other positions as well. Each of these positions provides patients with the support and help they need to make their fight against cancer a worthwhile effort.

To Learn More Click Here

Dr. David Samadi Reveals Some Truths About Prostate Cancer And Its Possible Treatments

Mitt Romney, recently disclosed that he had prostate surgery last year on a tumor that was slowly growing before it was taken care of. It is likely that he did so because he plans on running for the United States Senate in Utah once the seat is vacated. Dr. David Samadi revealed that Dr. Thomas Ahlering from UC Irvine Hospital completed the surgery, and he also revealed that Mitt is in good shape now. In 2017 there were more than 161,000 men who were diagnosed with prostate cancer, and in 2018 it is expected that there will be over 164,000 men diagnosed with the disease. It is unique for men under the age of 40 to get prostate cancer, but 60% of men over the age of 65 do.

Mitt Romney was 70 years old when he was diagnosed with prostate cancer, but he isn’t the only politician to come out of prostate cancer surgery with good news. Colin Powell, in 2003, had his prostate gland removed, and John Kerry, during his presidential run, also underwent surgery for prostate cancer and never had any issues after. The truth is, there are two options for a man to consider once he has been diagnosed with prostate cancer, and Dr. David Samadi has commented on the fact that he always goes over these options with his patients, which are radiation treatment or surgery. If the prostate cancer has not spread beyond itself, Dr. Samadi usually recommends his patients to get surgery.

Dr. David Samadi has talked about the reasons why he recommends surgery over radiation in most cases. One of these reasons is that men who receive radiation are two times as likely to die afterwards from the cancer and just a bit less likely to die earlier than men who had surgery. Exposure to radiation can also cause other kinds of cancer, and patients who first get radiation therapy have a much harder time being good candidates for surgery afterwards.

Dr. David Samadi is the Chief of Robotic Surgery and the Chairman of Urology at Lenox Hill Hospital. He was born in Iran but moved to Belgium, London, and then the United States after leaving the country during the Iranian Revolution. He studied at Stony Brook University in New York where he earned a degree in biochemistry and went on the receive his M.D. from New York’s S.U.N.Y., Stony Brook School of Medicine.

Learn More: www.huffingtonpost.com/author/dr-david-samadi

Dr. Clay Siegall, The Hope of Cancer Treatment

Clay Siegall serves as the President and the Chief Executive Officer (CEO) of the Seattle Genetics, Inc. He is also the chairman of the board of the company. He is the co-founder the company that is accredited for scientific innovations particularly in the treatment of cancer. His education background is the field of science where he pursued a B.S in Zoology at the University of Maryland and later obtained his Ph.D. in genetics from George Washington University.

Similarly, Dr. Clay has much experience in cancer research and development of treatment therapies. Besides, he is the author of at least 67 journal papers that are scientific and have several patents. His career began in 1988 as a fellow at the National Cancer Institute within the National Institutes of Health until 1991. In 1995, Dr. Clay received Pierce Award for his excellent work pertaining targeted toxins. He was also awarded in 2002 the Ernst and Young Entrepreneur of the Year in the category of healthcare.

Furthermore, he served as a senior research investigator at the Bristol-Myers Squibb Pharmaceutical Research Institute between the year 1991 and 1995. He also served as the principal scientist in the same organizations until 1997 when he co-founded Seattle Genetics. He was the director of Alder, Biopharmaceuticals Inc., Washington Biotechnology, and Biomedical Association. Similarly, he served as the on the board of governors of the Fred Hutchinson Cancer Research business alliance.

Besides working in various scientific institutions, Dr. Clay is a member of the Cancer Treatment Research Foundation. He also serves on the editorial board of three scientific journals. He lays much emphasis on targeted therapies relating to cancer. Under his leadership, Seattle Genetics has developed an antibody-drug conjugates product that was approved by the FDA in 2011. The company collaborated with Takeda Pharmaceuticals to develop ADCETRIS drug used in cancer treatment.

Finally, Clay Siegall has portrayed strategic leadership enabling Seattle Genetics to partner with pharmaceuticals like Pfizer in ADC technology. He helped raise capital from the public and private to develop the company. In addition, Dr. Clay is driven by the need to help the patients, thus reduce the impact of cancer in the society.